Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

HYEONG SU KIM; JUNG HAN KIM; HEE JUN KIM; HYUN JOO JANG; JIN BAE KIM; JI WON KIM; SO YOUNG JUNG; BYUNG CHUN KIM; DAE HYUN YANG; SOAH PARK; KEONG JU KIM; SOON IL LEE; DAE YOUNG ZANG

doi:10.3892/ol.2011.496

Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

Oncology Letters ◽

10.3892/ol.2011.496 ◽

2011 ◽

Vol 3 (2) ◽

pp. 425-428 ◽

Cited By ~ 9

Author(s):

HYEONG SU KIM ◽

JUNG HAN KIM ◽

HEE JUN KIM ◽

HYUN JOO JANG ◽

JIN BAE KIM ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

First Line ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Download Full-text

Comparative Analysis of the Efficacy and Safety of Oxaliplatin Plus 5-Fluorouracil/Leucovorin (Modified FOLFOX6) with Advanced Gastric Cancer Patients having a Good or Poor Performance Status

Asian Pacific Journal of Cancer Prevention ◽

10.7314/apjcp.2015.16.6.2355 ◽

2015 ◽

Vol 16 (6) ◽

pp. 2355-2359 ◽

Cited By ~ 2

Author(s):

Ilhan Hacibekiroglu ◽

Hilmi Kodaz ◽

Bulent Erdogan ◽

Esma Turkmen ◽

Asim Esenkaya ◽

...

Keyword(s):

Gastric Cancer ◽

Comparative Analysis ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Efficacy And Safety ◽

Modified Folfox6 ◽

Gastric Cancer Patients

Download Full-text

A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status

Pharmacogenetics and Genomics ◽

10.1097/fpc.0000000000000320 ◽

2018 ◽

Vol 28 (1) ◽

pp. 23-30 ◽

Cited By ~ 2

Author(s):

Mi-Jung Kim ◽

Sun-Young Kong ◽

Byung-Ho Nam ◽

Sohee Kim ◽

Young-Iee Park ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii Study ◽

Performance Status ◽

Poor Performance ◽

Metastatic Gastric Cancer ◽

Poor Performance Status ◽

First Line ◽

Randomized Phase Ii ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Download Full-text

Efficacy and safety of liposome-paclitaxel/liposome-paclitaxel combined with S-1 in 17 advanced gastric cancer patients with poor performance status

Translational Cancer Research ◽

10.21037/tcr.2019.08.17 ◽

2019 ◽

Vol 8 (5) ◽

pp. 1690-1698 ◽

Cited By ~ 1

Author(s):

Runhong Wu ◽

Zhu Shen ◽

Na Yu ◽

Jianhao Xu ◽

Xuya Yuan ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Efficacy And Safety ◽

Paclitaxel Liposome ◽

Gastric Cancer Patients

Download Full-text

A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status

British Journal of Cancer ◽

10.1038/sj.bjc.6603902 ◽

2007 ◽

Vol 97 (4) ◽

pp. 458-463 ◽

Cited By ~ 16

Author(s):

H-C Jeung ◽

S Y Rha ◽

S J Shin ◽

J B Ahn ◽

S H Noh ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Gastric Cancer Patients

Download Full-text

Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status

Medicine ◽

10.1097/md.0000000000017890 ◽

2019 ◽

Vol 98 (45) ◽

pp. e17890 ◽

Cited By ~ 1

Author(s):

Jianxin Chen ◽

Junhui Wang ◽

Qian Miao

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Line Treatment ◽

Dose Modification ◽

Gastric Cancer Patients

Download Full-text

A Phase II Feasibility Study of Weekly Paclitaxel in Heavily Pretreated Advanced Gastric Cancer Patients with Poor Performance Status

Oncology ◽

10.1159/000265941 ◽

2009 ◽

Vol 77 (6) ◽

pp. 349-357 ◽

Cited By ~ 4

Author(s):

Chong Kun Im ◽

Sun Young Rha ◽

Hei-Cheul Jeung ◽

Jaeheon Jeong ◽

Soo Hyeon Lee ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Feasibility Study ◽

Phase Ii ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Heavily Pretreated ◽

Gastric Cancer Patients

Download Full-text

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

Journal of Translational Medicine ◽

10.1186/s12967-018-1385-y ◽

2018 ◽

Vol 16 (1) ◽

Cited By ~ 6

Author(s):

Elisa Melucci ◽

Beatrice Casini ◽

Livia Ronchetti ◽

Laura Pizzuti ◽

Francesca Sperati ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Wnt Pathway ◽

Survival Outcomes ◽

First Line ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Download Full-text

Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients

Annals of Oncology ◽

10.1093/annonc/mdl174 ◽

2006 ◽

Vol 17 (11) ◽

pp. 1665-1672 ◽

Cited By ~ 26

Author(s):

W. Ichikawa ◽

Y. Sasaki

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Tumor Response ◽

First Line ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Download Full-text

Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapy

Annals of Translational Medicine ◽

10.21037/atm.2020.02.131 ◽

2020 ◽

Vol 8 (6) ◽

pp. 311-311

Author(s):

Jin Wang ◽

Bowen Yang ◽

Zhi Li ◽

Jinglei Qu ◽

Jing Liu ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Performance Status ◽

Metastatic Gastric Cancer ◽

First Line ◽

Good Performance Status ◽

Prediction Of Survival ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Download Full-text

Survival after failure of first-line chemotherapy in advanced gastric cancer patients: differences between Japan and the rest of the world

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyx044 ◽

2017 ◽

Vol 47 (7) ◽

pp. 583-589 ◽

Cited By ~ 5

Author(s):

Atsuo Takashima ◽

Sakura Iizumi ◽

Narikazu Boku

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

First Line ◽

The World ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Download Full-text